UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Purinergic signalling, ISSN 1573-9538, 9/2012, Volume 8, Issue 3, pp. 419 - 436
Clinical trials, nucleosides | Neurosciences | Adenosine receptors | Human Physiology | P2Y receptors | Antagonists | Nucleotides | Biomedicine general | Biomedicine | GPCR structure | Cancer Research | Agonists | Pharmacology/Toxicology | Biochemistry & Molecular Biology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Receptors, G-Protein-Coupled - metabolism | Humans | Purinergic P2Y Receptor Agonists - therapeutic use | Purinergic P1 Receptor Agonists - therapeutic use | Purinergic P1 Receptor Antagonists - pharmacology | Receptors, Purinergic P1 - chemistry | Receptors, Purinergic P2 - chemistry | Drug Design | Receptors, G-Protein-Coupled - drug effects | Purinergic P2Y Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Antagonists - pharmacology | Purinergic P1 Receptor Agonists - chemistry | Purinergic P1 Receptor Agonists - pharmacology | Purinergic P1 Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Agonists - chemistry | Clinical Trials as Topic | Receptors, Purinergic P2 - drug effects | Purinergic P2Y Receptor Agonists - pharmacology | Animals | Purinergic P2Y Receptor Antagonists - chemistry | Receptors, Purinergic P2 - metabolism | Ligands | Receptors, Purinergic P1 - metabolism | Receptors, Purinergic P1 - drug effects | Receptors, G-Protein-Coupled - chemistry | Purinergic P1 Receptor Antagonists - chemistry | Glaucoma | Heart | Adenosine | Parkinson's disease | Psoriasis | Cystic fibrosis | Rheumatoid factor | Hepatitis | Alkaloids | Pyrimidines | Heterocyclic compounds | Emissions (Pollution) | Rheumatoid arthritis | Respiratory tract diseases | Eye diseases | G proteins | Diabetes | Ophthalmology | Kidney diseases | Hepatitis C | DNA-ligand interactions | Index Medicus | Arrhythmia | Clinical trials | Ionizing radiation | Reperfusion | Ischemia | pyrimidines | Injuries | Movement disorders | Neurodegenerative diseases | Diabetes mellitus | Lung diseases | Pharmacology | Thrombosis | imaging | Stress | Purine P2Y receptors | purines | Hypoxia | Receptor mechanisms | ATP | Cancer | Pharmaceuticals | Original
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 01/2021, Volume 22, Issue 1, p. 383
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Residues | Transplants & implants | Molecular structure | Transcription | Gene regulation | Electrophysiology | Smooth muscle | Intracellular signalling | Segments | Neuroblastoma | Kinases | Oocytes | Receptors | Allosteric properties | Metabolites | Conflicts of interest | Physiology | Purine P2 receptors | Gametocytes | Localization | Vestibules | Hypertension | Ethanol | Cytokines | Channel gating | Muscles | Inflammation | Molecular modelling | Mutagenesis | Site-directed mutagenesis | Stem cells | Sepsis | Receptor mechanisms | Binding sites | Polymorphism | Structure-function relationships | Index Medicus | n/a
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 12/2014, Volume 15, Issue 12, pp. 23672 - 23704
Multiple sclerosis | Alzheimer’s disease | Glioma | Epilepsy | Depression | Neurodegenerative disease | P2Y receptors | ATP | P2X receptors | Neuropathic pain | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Receptors, Purinergic P2Y - chemistry | Receptors, Purinergic P2X - chemistry | Humans | Nervous System Diseases - drug therapy | Receptors, Purinergic P2Y - metabolism | Purinergic P2 Receptor Antagonists - therapeutic use | Nervous System Diseases - genetics | Receptors, Purinergic P2X - genetics | Purinergic P2 Receptor Agonists - therapeutic use | Animals | Purinergic P2 Receptor Antagonists - pharmacology | Receptors, Purinergic P2X - metabolism | Nervous System Diseases - metabolism | Purinergic P2 Receptor Agonists - pharmacology | Receptors, Purinergic P2Y - genetics | Alzheimers disease | Neurological disorders | Index Medicus | epilepsy | neuropathic pain | neurodegenerative disease | multiple sclerosis | glioma | Review | depression
Journal Article
Purinergic signalling, ISSN 1573-9538, 12/2013, Volume 9, Issue 4, pp. 491 - 540
Neurosciences | Cell growth | Biomedicine | Human Physiology | P2 receptors | Anti-cancer drugs | Cancer Research | Extracellular ATP | Pharmacology/Toxicology | Biomedicine general | Apoptosis | Cancer | Biochemistry & Molecular Biology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | Animals | Signal Transduction | Models, Biological | Purines - metabolism | Adenosine Triphosphate - metabolism | Humans | Neoplasm Proteins - metabolism | Receptors, Purinergic - metabolism | Medical colleges | Care and treatment | Cell death | Oncology, Experimental | Research | Nucleotides | Cells | Index Medicus | Review
Journal Article